Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ambrus

Showing results (101-110 of 164) with videos related to

Pageof 17
Sort By:
Journal of Medicine|December 19, 2007
Multiple medical problems following agent orange exposureJ L Ambrus, A Islam, S Akhter, et al.
New York State Journal of Medicine|July 1, 1974
Fibrin-fibrinogen degradation products in children with renal diseaseJ L Ambrus, T Baliah, C M Ambrus, et al.
Journal of Medicine|January 1, 1984
Studies on the management and prevention of vasoocclusive crisis in sickle cell diseaseJ L Ambrus, C M Ambrus, R Bannerman, et al.
Journal of Medicine|January 1, 1982
Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysisJ L Ambrus, C M Ambrus, S D Sharma, et al.
Current Therapeutic Research, Clinical and Experimental|July 1, 1970
Clinical pharmacologic study of an isoquinoline derivative (EN 1661) and of its ability to induce fibrinolytic activity in the circulation of manJ L Ambrus, C M Ambrus, R Jacobsen, et al.
Acta Medica Academiae Scientiarum Hungaricae|January 1, 1980
Serologic studies of hepatitis viruses for their aetiologic role in chronic liver diseaseA Pár, I Hollós, G Bajtai, et al.
Acta Medica Academiae Scientiarum Hungaricae|January 1, 1980
Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitisA Pár, K Barna, G Bajtai, et al.
Journal of Medicine|January 1, 1979
Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifyllineJ L Ambrus, C M Ambrus, H Gastpar, et al.
Clinical Nephrology|September 1, 1979
The role of hepatitis B surface antigen in the pathogenesis of glomerulopathiesJ Nagy, G Bajtai, H Brasch, et al.
Lancet (London, England)|August 5, 1978
HBsaG in renal diseaseJ Nagy, G Bajtai, H Brasch, et al.
Pageof 17

Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
Journal of Medicine|December 19, 2007
Multiple medical problems following agent orange exposureJ L Ambrus, A Islam, S Akhter, et al.
New York State Journal of Medicine|July 1, 1974
Fibrin-fibrinogen degradation products in children with renal diseaseJ L Ambrus, T Baliah, C M Ambrus, et al.
Journal of Medicine|January 1, 1984
Studies on the management and prevention of vasoocclusive crisis in sickle cell diseaseJ L Ambrus, C M Ambrus, R Bannerman, et al.
Journal of Medicine|January 1, 1982
Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysisJ L Ambrus, C M Ambrus, S D Sharma, et al.
Current Therapeutic Research, Clinical and Experimental|July 1, 1970
Clinical pharmacologic study of an isoquinoline derivative (EN 1661) and of its ability to induce fibrinolytic activity in the circulation of manJ L Ambrus, C M Ambrus, R Jacobsen, et al.
Acta Medica Academiae Scientiarum Hungaricae|January 1, 1980
Serologic studies of hepatitis viruses for their aetiologic role in chronic liver diseaseA Pár, I Hollós, G Bajtai, et al.
Acta Medica Academiae Scientiarum Hungaricae|January 1, 1980
Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitisA Pár, K Barna, G Bajtai, et al.
Journal of Medicine|January 1, 1979
Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifyllineJ L Ambrus, C M Ambrus, H Gastpar, et al.
Clinical Nephrology|September 1, 1979
The role of hepatitis B surface antigen in the pathogenesis of glomerulopathiesJ Nagy, G Bajtai, H Brasch, et al.
Lancet (London, England)|August 5, 1978
HBsaG in renal diseaseJ Nagy, G Bajtai, H Brasch, et al.
Pageof 17